Jacek Lubelski

Company: NanoCell Therapeutics

Job title: Chief Technology Officer

Seminars:

Discussing Non-Viral Delivery of DNA to Spotlight this Unique Approach to In Vivo CAR-T 9:00 am

Highlighting non-viral delivery mechanisms to engineer cells in vivo Understanding the advantages and disadvantages of this mode of delivery compared to other forms Sharing insights from the NanoCell technology platformRead more

day: Conference Day Two

Industry Leader’s Fireside Chat: Supercharging In Vivo as the Frontier of Cell Therapy & Comparing to Ex Vivo 9:00 am

Accentuating the bottlenecks of ex vivo therapies, such as the need for costly manufacturing processes and limited access, to consider the need to move towards a new engineering technique Championing in vivo therapies by highlighting the solutions they could bring to the ex vivo cell therapy and gene editing field Reaffirming the shift of interest…Read more

day: Conference Day One